• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    1/10/23 2:11:52 PM ET
    $ACCD
    $ALXO
    $AMAM
    $AMRN
    Business Services
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACCD alert in real time by email

    Gainers

    • Sotera Health Company (NASDAQ:SHC) shares jumped 92% to $16.59 after the company announced its subsidiaries have reached agreements to settle the Ethylene Oxide cases pending against Sterigenics. Sterigenics will pay the company $408 million to settle the claims.
    • Party City Holdco Inc. (NYSE:PRTY) gained 54% to $0.3193 following an Axios report suggesting The Franchise Group could be looking at acquiring the company.
    • Panbela Therapeutics, Inc. (NASDAQ:PBLA) shares rose 51.1% to $0.1224 after gaining 4% on Monday.
    • VYNE Therapeutics Inc. (NASDAQ:VYNE) climbed 50.5% to $0.2892 after the company announced the first vitiligo patient was dosed in a Phase 1a/b clinical trial of VYN201.
    • Elys Game Technology, Corp. (NASDAQ:ELYS) jumped 49.5% to $0.6276.
    • Boxed, Inc. (NYSE:BOXD) gained 36.6% to $0.5191 after the company announced its Spresso Saas modular solution platform is now available on Google Cloud.
    • Biora Therapeutics, Inc. (NASDAQ:BIOR) rose 35% to $2.85. HC Wainwright & Co. maintained Biora Therapeutics with a Buy.
    • DermTech, Inc. (NASDAQ:DMTK) shares climbed 32.6% to $2.88 after DermTech announced the foundational assay of its DermTech Melanoma Test (DMT) is recommended for coverage by TRICARE.
    • DatChat, Inc. (NASDAQ:DATS) gained 31.7% to $0.48 after the company announced a $2 million stock repurchase plan.
    • POET Technologies Inc. (NASDAQ:POET) gained 31.3% to $4.2750.
    • Jianzhi Education Technology Group Company Limited (NASDAQ:JZ) gained 30% to $1.5657.
    • Rubius Therapeutics, Inc. (NASDAQ:RUBY) jumped 29.4% to $0.2349.
    • Oak Street Health, Inc. (NYSE:OSH) gained 28.4% to $28.99 as CVS Health is reportedly exploring an acquisition of primary care center operator.
    • BTCS Inc. (NASDAQ:BTCS) jumped 28.2% to $1.3199 after the company launched a private beta of its digital asset analytic and staking-as-a-service platform StakeSeeker.
    • Frontline plc (NYSE:FRO) rose 27.1% to $14.40. Frontline announced termination of combination agreement with Euronav.
    • Schmitt Industries, Inc. (NASDAQ:SMIT) gained 27.1% to $0.3879.
    • Prenetics Global Limited (NASDAQ:PRE) gained 25.6% to $2.3880 after the company announced its ACT Genomics received clearance from the FDA for ACTOnco.
    • NeuroPace, Inc. (NASDAQ:NPCE) jumped 25.2% to $2.04. NeuroPace announced preliminary unaudited Q4 revenue of $12.8 million and FY22 revenue of $45.5 million.
    • Bright Health Group, Inc. (NYSE:BHG) gained 24% to $0.8050 after the company announced it increased 2023 Enterprise Revenue guidance to $3.4 - $3.6 billion.
    • Frequency Therapeutics, Inc. (NASDAQ:FREQ) rose 24% to $4.13.
    • Ambrx Biopharma Inc. (NASDAQ:AMAM) jumped 23.5% to $2.62.
    • Accolade, Inc. (NASDAQ:ACCD) rose 23.5% to $9.58 after the company reported better-than-expected Q3 EPS and sales results and issued FY23 revenue guidance above estimates.
    • Kura Sushi USA, Inc. (NASDAQ:KRUS) gained 21.4% to $52.24. Kura Sushi recently reported worse-than-expected Q1 EPS and sales results.
    • Titan Medical Inc. (NASDAQ:TMDI) rose 20.4% to $1.1195.
    • Tuesday Morning Corporation (NASDAQ:TUEM) gained 19.4% to $0.74.
    • Summit Therapeutics Inc. (NASDAQ:SMMT) climbed 17.8% to $4.4438. Summit Therapeutics said on January 6, 2023, the company held meeting to vote on increase number of authorized shares of common stock by 650 million shares.
    • Amarin Corporation plc (NASDAQ:AMRN) gained 17.2% to $1.7350 after the company reported preliminary Q4 and FY22 revenue results above estimates.
    • Bed Bath & Beyond Inc. (NASDAQ:BBBY) rose 17.1% to $1.8975 despite the company turning in worse-than-expected financial results.
    • Satixfy Communications Ltd. (NYSE:SATX) gained 16.3% to $7.49.
    • Versus Systems Inc. (NASDAQ:VS) rose 15.3% to $0.6990 after jumping over 16% on Monday.
    • CureVac N.V. (NASDAQ:CVAC) gained 14.8% to $11.90.
    • Vericel Corporation (NASDAQ:VCEL) rose 14% to $27.25 after the company reported preliminary FY22 revenue results.
    • Rain Oncology Inc. (NASDAQ:RAIN) gained 13.9% to $13.23.
    • Oatly Group AB (NASDAQ:OTLY) jumped 12.3% to $2.6750 after the company announced an expansion of its partnership with Reitan to feature oat drink in coffee machines in its 7-Eleven and Pressbyrån convenience stores across Sweden.
    • Comstock Inc. (NYSE:LODE) shares rose 11.9% to $0.4498.
    • Heska Corporation (NASDAQ:HSKA) gained 10.3% to $74.34. Heska CEO and President Kevin S Wilson bought a total of 11,018 shares at an average price of $58.62.


    Losers

    • Peak Bio, Inc. (NASDAQ:PKBO) dropped 58.2% to $2.09.
    • BioAtla, Inc. (NASDAQ:BCAB) shares fell 46.2% to $4.1550 after the company provided clinical program updates and upcoming 2023 milestones.
    • BIOLASE, Inc. (NASDAQ:BIOL) fell 46.5% to $0.3705 after the company announced pricing of $9.75 million offering.
    • Rayonier Advanced Materials Inc. (NYSE:RYAM) fell 30.6% to $6.35. RBC Capital downgraded Rayonier Adv
    • Materials from Outperform to Sector Perform and lowered the price target from $9 to $8.
    • Calithera Biosciences, Inc. (NASDAQ:CALA) dipped 25.3% to $0.4931. Calithera Biosciences shares dipped around 82% on Monday after its board of directors determined to dissolve the company and liquidate its assets. Also, the company will discontinue all clinical development programs and reduce its workforce.
    • Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) fell 17.6% to $0.5510.
    • Euronav NV (NYSE:EURN) shares fell 16.9% to $13.24.
    • IsoPlexis Corporation (NASDAQ:ISO) dipped 15.3% to $1.33.
    • Lucira Health, Inc. (NASDAQ:LHDX) dropped 14.8% to $0.3438.
    • Midatech Pharma plc (NASDAQ:MTP) fell 14.7% to $0.81.
    • Berkeley Lights, Inc. (NASDAQ:BLI) dropped 13.7% to $2.2850 after the company issued FY22 revenue guidance below analyst estimates.
    • ALX Oncology Holdings Inc. (NASDAQ:ALXO) fell 12% to $9.22.
    • Virgin Orbit Holdings, Inc. (NASDAQ:VORB) fell 11.7% to $1.70. Virgin Orbit shared its readiness for the Start Me Up mission for a historic U.K. launch on January 9.
    • G Medical Innovations Holdings Ltd (NASDAQ:GMVD) fell 10.9% to $3.9812 after jumping 42% on Monday.
    • Argo Blockchain plc (NASDAQ:ARBK) fell 9.5% to $1.2850.
    • Super Micro Computer, Inc. (NASDAQ:SMCI) fell 8.4% to $77.67 after Spruce Point Management issued a bearish report on the stock.
    • Apexigen, Inc. (NASDAQ:APGN) fell 7.2% to $1.67 after gaining around 91% on Monday.
    • Box, Inc. (NYSE:BOX) fell 6.3% to $27.96. RBC Capital downgraded Box from Sector Perform to Underperform and lowered the price target from $28 to $24.

    Also Check This Out Ethereum Remains Above This Key Level; Aptos Emerges As Top Gainer

    Get the next $ACCD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACCD
    $ALXO
    $AMAM
    $AMRN

    CompanyDatePrice TargetRatingAnalyst
    Summit Therapeutics Inc.
    $SMMT
    4/8/2026$45.00Buy
    Stifel
    Super Micro Computer Inc.
    $SMCI
    3/23/2026$22.00Outperform → Market Perform
    Northland Capital
    Box Inc.
    $BOX
    3/23/2026Outperform → Mkt Perform
    William Blair
    Super Micro Computer Inc.
    $SMCI
    3/20/2026Buy → Hold
    Argus
    Super Micro Computer Inc.
    $SMCI
    3/20/2026Market Perform → Market Underperform
    CJS Securities
    ALX Oncology Holdings Inc.
    $ALXO
    3/19/2026$5.00Overweight
    Wells Fargo
    Prenetics Global Limited
    $PRE
    3/16/2026$29.00Buy
    Lake Street
    Summit Therapeutics Inc.
    $SMMT
    3/16/2026$15.00Buy → Hold
    Jefferies
    More analyst ratings

    $ACCD
    $ALXO
    $AMAM
    $AMRN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026

    CAMBRIDGE, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will report its first-quarter 2026 financial results on Thursday, May 7, 2026. Vericel's management will host a conference call and webcast at 8:30 a.m. ET to discuss its financial results and business highlights. The live webcast can be accessed on the Investor Relations section of the Vericel website at http://investors.vcel.com/events-presentations. Presentation slides for the conference call will be available on the webcast and on the website. A replay of the webcast will be availab

    4/23/26 8:30:00 AM ET
    $VCEL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    The Container Store Launches Nationwide Overhaul Across 98 Stores

    30% category and SKU liquidation required to make way for Bed Bath & Beyond merger The Container Store today announced the launch of a chainwide "Store Changing" event beginning Friday, April 24, as 98 stores nationwide begin resetting selling floors to prepare for the phased integration of Bed Bath & Beyond products. As part of the reset, the Company will liquidate approximately 30% of select categories and SKUs beginning Friday to streamline assortments, improve space productivity and create room for new products expected to arrive in phases later this year. The initiative is a planned step in reimagining the combined in-store experience. "This is a reset with purpose," said Jen Pap

    4/23/26 8:00:00 AM ET
    $BBBY
    Catalog/Specialty Distribution
    Consumer Discretionary

    RYAM Schedules First Quarter 2026 Earnings Release

    Rayonier Advanced Materials (NYSE:RYAM) plans to release its first quarter 2026 earnings on Tuesday, May 5, 2026, after the market closes. RYAM will host a conference call and live webcast at 9:00 a.m. ET on Wednesday, May 6, 2026, to discuss these results. Supplemental materials and access to the live audio webcast will be available at www.RYAM.com. A replay of this webcast will be archived on the company's website shortly after the call. Investors may listen to the conference call by dialing 800-715-9871 (U.S. & Canada Toll-Free) or +1 (646) 307-1963 (International) and entering Conference ID 3159397. An audio replay of the teleconference will be available one hour after the call en

    4/22/26 4:30:00 PM ET
    $RYAM
    Paper
    Basic Materials

    $ACCD
    $ALXO
    $AMAM
    $AMRN
    SEC Filings

    View All

    Rayonier Advanced Materials Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - RAYONIER ADVANCED MATERIALS INC. (0001597672) (Filer)

    4/21/26 4:33:56 PM ET
    $RYAM
    Paper
    Basic Materials

    SEC Form DEFA14A filed by Neuropace Inc.

    DEFA14A - NeuroPace Inc (0001528287) (Filer)

    4/21/26 4:06:15 PM ET
    $NPCE
    Medical/Dental Instruments
    Health Care

    SEC Form DEF 14A filed by Neuropace Inc.

    DEF 14A - NeuroPace Inc (0001528287) (Filer)

    4/21/26 4:05:36 PM ET
    $NPCE
    Medical/Dental Instruments
    Health Care

    $ACCD
    $ALXO
    $AMAM
    $AMRN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Tabacco Joseph J Jr bought $102,200 worth of shares (20,000 units at $5.11) (SEC Form 4)

    4 - BED BATH & BEYOND, INC. (0001130713) (Issuer)

    3/12/26 8:32:43 PM ET
    $BBBY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Director Goodman Corey S bought $4,999,999 worth of shares (3,184,713 units at $1.57) (SEC Form 4)

    4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)

    2/4/26 4:15:59 PM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CEO Allen Charles W bought $261,425 worth of shares (90,500 units at $2.89), increasing direct ownership by 2% to 4,666,506 units (SEC Form 4)

    4 - BTCS Inc. (0001436229) (Issuer)

    11/19/25 5:27:18 PM ET
    $BTCS
    Finance: Consumer Services
    Finance

    $ACCD
    $ALXO
    $AMAM
    $AMRN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Levie Aaron was granted 1,954 shares and covered exercise/tax liability with 791 shares, increasing direct ownership by 0.04% to 2,908,193 units (SEC Form 4)

    4 - BOX INC (0001372612) (Issuer)

    4/23/26 5:40:49 PM ET
    $BOX
    Computer Software: Prepackaged Software
    Technology

    Chief Financial Officer Smith Dylan C was granted 4,614 shares and covered exercise/tax liability with 2,316 shares, increasing direct ownership by 0.16% to 1,404,769 units (SEC Form 4)

    4 - BOX INC (0001372612) (Issuer)

    4/23/26 5:39:28 PM ET
    $BOX
    Computer Software: Prepackaged Software
    Technology

    Chief Operating Officer Nottebohm Olivia was granted 4,343 shares and covered exercise/tax liability with 2,180 shares, increasing direct ownership by 0.38% to 577,151 units (SEC Form 4)

    4 - BOX INC (0001372612) (Issuer)

    4/23/26 5:37:46 PM ET
    $BOX
    Computer Software: Prepackaged Software
    Technology

    $ACCD
    $ALXO
    $AMAM
    $AMRN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Stifel initiated coverage on Summit Therapeutics with a new price target

    Stifel initiated coverage of Summit Therapeutics with a rating of Buy and set a new price target of $45.00

    4/8/26 8:38:26 AM ET
    $SMMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Super Micro Computer downgraded by Northland Capital with a new price target

    Northland Capital downgraded Super Micro Computer from Outperform to Market Perform and set a new price target of $22.00

    3/23/26 8:27:58 AM ET
    $SMCI
    Computer Manufacturing
    Technology

    Box downgraded by William Blair

    William Blair downgraded Box from Outperform to Mkt Perform

    3/23/26 8:25:07 AM ET
    $BOX
    Computer Software: Prepackaged Software
    Technology

    $ACCD
    $ALXO
    $AMAM
    $AMRN
    Leadership Updates

    Live Leadership Updates

    View All

    ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer

    - Veteran biopharmaceutical and oncology leader brings more than three decades of experience across clinical development, regulatory, and operational execution SOUTH SAN FRANCISCO, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. (("ALX Oncology, NASDAQ:ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, announced the appointment of Jeff Knight, M.P.H., as Chief Development and Operating Officer, effective April 13, 2026. "Jeff is a highly accomplished leader with deep expertise across clinical development and operations, and a strong track record of both advancing innovative thera

    4/13/26 8:30:00 AM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Bed Bath & Beyond Names Veteran Retail Operator Amy Sullivan President

    Bed Bath & Beyond, Inc. (NYSE:BBBY) ("Bed Bath & Beyond" or the "Company"), owner of Bed Bath & Beyond, Overstock, buybuy BABY, Kirkland's, and a blockchain asset portfolio, today announced the appointment of Amy Sullivan as President, effective immediately, as the Company accelerates its next phase of disciplined growth. Sullivan is a merchant and operator who built her career across some of retail's most recognized brands, including JCPenney, Kohl's, Lands' End, Express, and Lane Bryant, before joining Kirkland's in 2012, where she rose from divisional merchandise manager to President and CEO. As CEO of The Brand House Collective, the operating entity she led through its transformation

    4/6/26 8:30:00 AM ET
    $BBBY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Comstock Inc. Appoints Three New Independent Directors as Company Accelerates Growth in Solar Recycling and Critical Metals Recovery

    VIRGINIA CITY, Nev., March 24, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE:LODE) ("Comstock" or the "Company"), a leader in converting under-utilized natural resources into renewable energy products and the only certified, zero-landfill solar recycling solution in North America, today announced the appointment of Donald A. Colvin, Steven Y. Pei and Robert M. Spence as independent directors to the Company's Board of Directors, effective immediately. Mr. Colvin will serve on the Company's Audit and Finance Committee once necessary approvals have been obtained, bringing world-class financial oversight credentials and direct solar sector board leadership experience to that role. Walter "Del"

    3/24/26 4:05:00 PM ET
    $LODE
    Major Chemicals
    Industrials

    $ACCD
    $ALXO
    $AMAM
    $AMRN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Accolade Inc.

    SC 13G/A - Accolade, Inc. (0001481646) (Subject)

    11/14/24 7:34:26 PM ET
    $ACCD
    Business Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Versus Systems Inc.

    SC 13G/A - Versus Systems Inc. (0001701963) (Subject)

    11/14/24 7:30:32 PM ET
    $VS
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by ALX Oncology Holdings Inc.

    SC 13G/A - ALX ONCOLOGY HOLDINGS INC (0001810182) (Subject)

    11/14/24 7:22:54 PM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACCD
    $ALXO
    $AMAM
    $AMRN
    Financials

    Live finance-specific insights

    View All

    Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026

    CAMBRIDGE, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will report its first-quarter 2026 financial results on Thursday, May 7, 2026. Vericel's management will host a conference call and webcast at 8:30 a.m. ET to discuss its financial results and business highlights. The live webcast can be accessed on the Investor Relations section of the Vericel website at http://investors.vcel.com/events-presentations. Presentation slides for the conference call will be available on the webcast and on the website. A replay of the webcast will be availab

    4/23/26 8:30:00 AM ET
    $VCEL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    RYAM Schedules First Quarter 2026 Earnings Release

    Rayonier Advanced Materials (NYSE:RYAM) plans to release its first quarter 2026 earnings on Tuesday, May 5, 2026, after the market closes. RYAM will host a conference call and live webcast at 9:00 a.m. ET on Wednesday, May 6, 2026, to discuss these results. Supplemental materials and access to the live audio webcast will be available at www.RYAM.com. A replay of this webcast will be archived on the company's website shortly after the call. Investors may listen to the conference call by dialing 800-715-9871 (U.S. & Canada Toll-Free) or +1 (646) 307-1963 (International) and entering Conference ID 3159397. An audio replay of the teleconference will be available one hour after the call en

    4/22/26 4:30:00 PM ET
    $RYAM
    Paper
    Basic Materials

    Supermicro to Report Third Quarter Fiscal 2026 Financial Results on May 5th, 2026

    Super Micro Computer, Inc. (SMCI), an AI, Enterprise, Storage, 5G/Edge Total Solution Provider with optimized Data Center Building Block Solutions (DCBBS), today announced that it will host its third quarter fiscal 2026 financial results conference call on Tuesday, May 5th, 2026, at 5:00 p.m. ET / 2:00 p.m. PT. The webcast will be available at https://ir.supermicro.com. A replay of the webcast will be available shortly after the call at the same website and will remain accessible for one year. About Super Micro Computer, Inc. Supermicro (NASDAQ:SMCI) is a global leader in Application-Optimized Total IT Solutions. Founded and operating in San Jose, California, Supermicro is committed

    4/21/26 9:05:00 AM ET
    $SMCI
    Computer Manufacturing
    Technology